MiNK Therapeutics (INKT) Q2 2025 Earnings

May 15Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.8
-0.56
-0.31
-0.07

Details

Expected EPS
-0.6077
Actual EPS
-0.7
Surprise EPS
-0.09
Surprise Percent
-15.19%

Description

⁨MiNK Therapeutics⁩ (⁦INKT⁩) has reported earnings of ⁦-0.7⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts